STOCK TITAN

Verona Pharma plc (VRNA) Net Income by Year

VRNA

Verona Pharma plc reported a net loss of $173.4M in fiscal year 2024. This represents a decrease of 219.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Verona Pharma plc has filed alongside them.

FY2024 annual
Net Income -$173.4M
YoY -219.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VRNA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$173.4M-219.0%-$54.4M+20.9%-$68.7M-23.6%-$55.6M+14.7%-$65.1M-60.6%-$40.6M

VRNA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
Net Income$11.9M+116.8%-$16.3M+36.7%N/A-$43.0M-192.5%-$70.8M-704.3%-$25.8M-54.1%N/A-$14.7M+6.1%-$8.8M+50.4%-$16.7M+32.6%N/A-$15.6M-241.6%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Verona Pharma plc financials

Frequently Asked Questions

What was Verona Pharma plc's net income in fiscal year 2024?

Verona Pharma plc reported a net loss of $173.4M in fiscal year 2024.

How fast is Verona Pharma plc's net income growing?

Verona Pharma plc (VRNA) net income fell by 219.0% year over year, from -$54.4M to -$173.4M in fiscal year 2024.

How has Verona Pharma plc's net income changed over the years?

Across the 6 fiscal years this page covers, Verona Pharma plc (VRNA) net income went from -$40.6M in fiscal year 2019 to -$173.4M in fiscal year 2024.

Verona Pharma plc (VRNA) reported $11.9M in net income in Q2 2025. This represents an increase of 116.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Verona Pharma plc (VRNA) reported on that line in every period on record.